期刊文献+

血清7-AABs、CEA、ProGRP水平变化与肺癌患者预后的关系研究 被引量:4

Study on the relationship between serum levels of 7-AABs,CEA and ProGRP and prognosis of lung cancer patients
下载PDF
导出
摘要 目的观察肺癌患者血清7种自身免疫性抗体(7-AABs)、癌胚抗原(CEA)、胃泌素释放肽前体(ProGRP)水平变化,并分析其临床意义。方法选取2015年8月-2017年8月在我院接受治疗的肺癌患者为研究对象,同时选取同期在我院接受检查的肺囊肿患者为对照。观察两组患者7-AABs、CEA、ProGRP水平的差异,比较不同预后的肺癌患者7-AABs、CEA、ProGRP水平的差异。结果观察组患者的抑癌基因产物p53、PGP 9.5、SOX2、GAGE7、ATP结合RNA解旋酶GBU4-5、MAGEA1、CAGE水平高于对照组患者(P<0.001);观察组患者的CEA、ProGRP水平分别为85.23±4.24μg/L、46.79±5.08pg/ml,高于对照组患者(P<0.001);存活组患者的抑癌基因产物p53、PGP 9.5、SOX2、GAGE7、ATP结合RNA解旋酶GBU4-5、MAG EA1、CAGE水平低于死亡组患者(P<0.001);存活组患者的CEA、ProGRP水平分别为18.92±2.35μg/L、30.25±4.12pg/ml,明显低于死亡组(t=-89.555、-17.447,P<0.001)。相关分析法结果显示,p53、ATP结合RNA解旋酶GBU4-5与患者预后密切相关(r=0.342、0.413,P<0.05)。结论肺癌患者血清7-AABs、CEA、ProGRP水平较高,且与患者的预后密切相关。 Objective The levels of seven autoimmune antibodies(7-AABs),carcinoembryonic antigen(CEA)and gastrin releasing peptide precursor(ProGRP)in lung cancer patients were detected and their clinical significance was analyzed.Methods Lung cancer patients who were treated in our hospital from August 2015 to August 2017 were selected as the study subjects,and lung cyst patients who were examined in our hospital during the same period were selected as the control group.The difference of 7-AABs,CEA and ProGRP levels between the two groups was observed.The differences of 7-AABs,CEA and ProGRP levels in lung cancer patients with different clinical characteristics and prognosis were compared.The factors influencing 7-AABs,CEA and ProGRP levels in lung cancer patients were analyzed.Results The levels of p53,PGP 9.5,SOX2,GAGE7,ATP-binding RNA helicase GBU4-5,MAGEA1 and CAGE in the observation group were higher than those in the control group(P<0.001);the levels of CEA and ProGRP in the observation group were 85.23±4.24 ug/L and 46.79±5.08pg/ml,respectively,higher than those in the control group(P<0.001);the levels of p53,PGP 9.5,SOX2,GAGE7 and AT in the survival group were higher than those in the control group(P<0.001).The levels of P-binding RNA helicase GBU4-5,MAGEA1 and CAGE in survival group were lower than those in death group(P<0.001),and the levels of CEA and ProGRP in survival group were 18.92±2.35 ug/L and 30.25±4.12 pg/ml,respectively,which were significantly lower than those in death group(t=-89.555,-17.447,P<0.001).Conclusion The serum levels of 7-AABs,CEA and ProGRP in patients with lung cancer are higher,and they are closely related to the prognosis of patients.
作者 李曼 翟成凯 张祥杰 Li Man;ZHAI Chengkai;ZHANG Xiangjie(Department of Respiratory and Critical Care Medicine,First People's Hospital of Xinxiang City,Xinxiang 453000,China)
出处 《实验与检验医学》 CAS 2020年第4期659-661,675,共4页 Experimental and Laboratory Medicine
基金 国家卫生计生委医药卫生科技发展计划项目,编号W2018JZC206 河南省医学科技攻关计划项目,编号2018062179。
关键词 肺癌 自身抗体 肿瘤标志物 预后 lung cancer autoantibodies tumor markers prognosis
  • 相关文献

参考文献11

二级参考文献107

  • 1张永杰,秦叔逵,王杰军,等.肠型胃癌中HDAC1与Oct4表达的相关性研究[J].中华临床医师杂志(电子版),2013,7(14):6387-6390.
  • 2Kozu Y, Maniwa T, Takahashi S, et al. Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer. J Cardiothorac Surg, 2013, 8(1): 106-112.
  • 3Wang CY, Huang MS, Huang MH, et al. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. J Surq Res, 2010, 163(2):45-50.
  • 4Matsuquma H, Nakahara R, Iqarashi S, et al. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. J "lhorac Cardiovasc Surg, 2008, 135(1): 44-49.
  • 5Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in theforthcoming (seventh) edition of the TNM classification of malignant tumours.J "[horac Oncol, 2007, 2(8): 706-714.
  • 6Muley T, Dienemann H, Ebert W, et al. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res, 2004, 24(3B): 1953-1956.
  • 7Pujol JL, Molinier O, Ebert W, et al. CYFRA 21-1 is a prognostic determinant in non-smaU-ceU lung cancer: results of a meta-analysis in 2,063 patients. BrJ Cancer, 2004, 90(11): 2097-2105.
  • 8Okada M, Nishio W, Sakamoto T, et al. Prognostic significance of pefioperative serum carcinoembryonic antigen in non-smaU cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann "Ihorac Surg 2004, 78(1): 216-221.
  • 9Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J, 2001, 18(6): 1059-1068.
  • 10Lee JS, Yoon A, Kalapurakal SK, et al. Expression of PS3 oncoprotein in non- small-cell lung cancer: A favorable prognostic factor. J Clin Oncol, 1995, 13(8): 1893-1903.

共引文献222

同被引文献38

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部